Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Annals of oncology
Year: 2016, Jahrgang: 28, Heft: 3, Pages: 497-504 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw610 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1093/annonc/mdw610
|
| Verfasserangaben: | S. Loibl, C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas,C. Denkert, H. Wiebringhaus, S. Kümmel, M. Warm, S. Paepke, M. Just, C. Hanusch, J. Hackmann, J.-U. Blohmer, M. Clemens, S. Dan Costa, B. Gerber, K. Engels, V. Nekljudova, G. von Minckwitz, M. Untch on behalf of the investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast (AGO-B) study groups |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 157196620X | ||
| 003 | DE-627 | ||
| 005 | 20220814112839.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180412r20172016xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/annonc/mdw610 |2 doi | |
| 035 | |a (DE-627)157196620X | ||
| 035 | |a (DE-576)50196620X | ||
| 035 | |a (DE-599)BSZ50196620X | ||
| 035 | |a (OCoLC)1341003144 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 245 | 1 | 0 | |a Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer |b a subanalysis of data from the randomized phase III GeparSepto trial |c S. Loibl, C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas,C. Denkert, H. Wiebringhaus, S. Kümmel, M. Warm, S. Paepke, M. Just, C. Hanusch, J. Hackmann, J.-U. Blohmer, M. Clemens, S. Dan Costa, B. Gerber, K. Engels, V. Nekljudova, G. von Minckwitz, M. Untch on behalf of the investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast (AGO-B) study groups |
| 264 | 1 | |c 2017 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 10 November 2016 | ||
| 500 | |a Gesehen am 12.04.2018 | ||
| 534 | |c 2016 | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology |d Amsterdam [u.a.] : Elsevier, 1990 |g 28(2017), 3, Seite 497-504 |h Online-Ressource |w (DE-627)320428796 |w (DE-600)2003498-2 |w (DE-576)098134345 |x 1569-8041 |7 nnas |a Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer a subanalysis of data from the randomized phase III GeparSepto trial |
| 773 | 1 | 8 | |g volume:28 |g year:2017 |g number:3 |g pages:497-504 |g extent:8 |a Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer a subanalysis of data from the randomized phase III GeparSepto trial |
| 856 | 4 | 0 | |u https://doi.org/10.1093/annonc/mdw610 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180412 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 3 | ||
| 999 | |a KXP-PPN157196620X |e 300596843X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["S. Loibl, C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas,C. Denkert, H. Wiebringhaus, S. Kümmel, M. Warm, S. Paepke, M. Just, C. Hanusch, J. Hackmann, J.-U. Blohmer, M. Clemens, S. Dan Costa, B. Gerber, K. Engels, V. Nekljudova, G. von Minckwitz, M. Untch on behalf of the investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast (AGO-B) study groups"]},"person":[{"display":"Loibl, Sibylle","given":"Sibylle","role":"aut","family":"Loibl"},{"display":"Schneeweiss, Andreas","given":"Andreas","role":"aut","family":"Schneeweiss"}],"recId":"157196620X","note":["Published online: 10 November 2016","Gesehen am 12.04.2018"],"title":[{"title_sort":"Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer","title":"Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer","subtitle":"a subanalysis of data from the randomized phase III GeparSepto trial"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["157196620X"],"doi":["10.1093/annonc/mdw610"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"recId":"320428796","id":{"zdb":["2003498-2"],"eki":["320428796"],"issn":["1569-8041"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Annals of oncology","subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology"}],"origin":[{"dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedKey":"1990"}],"part":{"text":"28(2017), 3, Seite 497-504","pages":"497-504","extent":"8","issue":"3","volume":"28","year":"2017"},"language":["eng"],"pubHistory":["1.1990 -"],"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"disp":"Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer a subanalysis of data from the randomized phase III GeparSepto trialAnnals of oncology","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}]} | ||
| SRT | |a LOIBLSIBYLDUALHER2BL2017 | ||